TREATMENT OF BRONCHOGENIC CARCINOMA. II. SMALL CELL.BRODER LE; COHEN MH; SELAWRY OS et al.1977; CANCER TREATM. REV.; G.B.; DA. 1977; VOL. 4; NO 4; PP. 219-260; BIBL. 6 P. 1/2Article

PHASE I STUDY OF THALICARPINE (NSC-68075), A PLANT ALKALOID OF NOVEL STRUCTURE.CREAVEN PJ; COHEN MH; SELAWRY OS et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 5; PP. 1001-1006; BIBL. 9 REF.Article

PHASEI: CLINICAL TRIAL OF WEEKLY AND DAILY TREATMENT WITH CAMPTOTHECIN (NSC-100880): CORRELATION WITH PRECLINICAL STUDIES = PHASEI: ESSAI CLINIQUE DE LA CAMPTOTHECINE (NSC100880) EN ADMINISTRATION HEBDOMADAIRE ET QUOTIDIENNE: CORRELATION AVEC LES ETUDES PRECLINIQUESMUGGIA FM; CREAVEN PJ; HANSEN HH et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 4; PP. 515-521; BIBL. 12REF.Serial Issue

PHASEI CLINICAL TRIAL OF WEEKLY ADMINISTRATION OF 4PRIME -DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-ETHYLIDENE-BETA -D-GLUCOPYRANOSIDE) (NSC-141540; VP-16213)CREAVEN PJ; NEWMAN SJ; SELAWRY OS et al.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 6; PP. 901-907; BIBL. 5REF.Article

A CONTROLLED CLINICAL TRIAL TESTING TWO POTENTIALLY NON-CROSS-RESISTANT CHEMOTHERAPEUTIC REGIMENS IN SMALL-CELL CARCINOMA OF THE LUNGBRODER LE; SELAWRY OS; CHARYULU KN et al.1981; CHEST; ISSN 0012-3692; USA; DA. 1981; VOL. 79; NO 3; PP. 327-335; BIBL. 31 REF.Article

THERAPY OF ADVANCED SQUAMOUS CARCINOMA OF THE LUNG. CYCLOPHOSPHAMIDE VERSUS "COMB".BODEY GP; LAGAKOS SW; GUTIERREZ AC et al.1977; CANCER; U.S.A.; DA. 1977; VOL. 39; NO 3; PP. 1026-1031; BIBL. 14 REF.Article

INTENSIVE COMBINED CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH NONRESECTABLE BRONCHOGENIC CARCINOMA = CHIMIOTHERAPIE ET RADIOTHERAPIE INTENSIVES ASSOCIEES CHEZ LES MALADES ATTEINTS DE CANCER BRONCHOGENE NON OPERABLEHANSEN HH; MUGGIA FM; ANDREWS R et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 2; PP. 315-324; BIBL. 1 P.Serial Issue

PHASE I CLINICAL TRIAL OF ISOPHOSPHAMIDE (NSC-109724).COHEN MH; CREAVEN PJ; TEJADA F et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 4; PP. 751-755; BIBL. 9 REF.Article

COMBINATION CHEMOTHERAPY OF ADVANCED LUNG CANCER. A RANDOMIZED TRIAL.HANSEN HH; SELAWRY OS; SIMON R et al.1976; CANCER; U.S.A.; DA. 1976; VOL. 38; NO 6; PP. 2201-2207; BIBL. 13 REF.Article

CLINICAL STUDY WITH BLEOMYCIN: TOLERANCE TO TWICE WEEKLY DOSAGE = ETUDE CLINIQUE DE LA BLEOMYCINE: TOLERANCE A L'ADMINISTRATION 2 FOIS PAR SEMAINEOHNUMA T; SELAWRY OS; HOLLAND JF et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 4; PP. 914-922; BIBL. 15REF.Serial Issue

INTENSIVE CHEMOTHERAPY OF SMALL CELL BRONCHOGENIC CARCINOMA.COHEN MH; CREAVEN PJ; FOSSIECK BE JR et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 3; PP. 349-354; BIBL. 20 REF.Article

THE SUPERIORITY OF CCNU IN THE TREATMENT OF ADVANCED HODGKIN'S DISEASE: CANCER AND LEUKEMIA GROUP B STUDYHANSEN HH; SELAWRY OS; PAJAK TF et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 1; PP. 14-18; BIBL. 14 REF.Article

CYCLOPHOSPHAMIDE AND CCNU IN THE TREATMENT OF INOPERABLE SMALL CELL CARCINOMA AND ADENOCARCINOMA OF THE LUNG.EDMONSON JH; LAGAKOS SW; SELAWRY OS et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 7; PP. 925-932; BIBL. 7 REF.Article